'Viral vaccines' presentation slideshows

PRIMARY IMMUNODEFICIENCY

2.21k views • 164 slides

Incremental GMPs for IMPs and QP Batch Certification

Incremental GMPs for IMPs and QP Batch Certification. Presented by: Karen S. Ginsbury For: IFF October 2009. Course Objective.

3.74k views • 92 slides

BIOE 301 Lecture Nine

546 views • 53 slides

BIOE 301

BIOE 301. Lecture Nine. Summary of Lecture 8. Pathogens: Bacteria and Virus Levels of Immunity: Barriers ? First line of defense Innate ? Inflammation Phagocytes Complement Adaptive ? Immunologic memory Antibody mediated immunity Cell mediated immunity ? Pathogens within cells.

690 views • 49 slides

Viruses Treatment and prevention

Viruses Treatment and prevention. Anti-Viral Chemotherapy. Bacteria Many antibiotics Highly selective Viruses Use host cell metabolism Selectivity difficult Toxicity. Anti-Viral Chemotherapy. Key is selectivity Other problems Toxicity Rapid excretion Rapid metabolism

673 views • 43 slides

7 th SEMINAR

7 th SEMINAR. VACCINATION, POLYCLONAL AND MONOCLINAL ANTIBODIES. THE FIRST VACCINE Edward Jenner - 1796. He proved that a vaccination with a weak pathogen isolated from another specie (cowpox) can grant immunity against a similar but dangerous human pathogen (smallpox).

519 views • 35 slides

Ch. 21. Cancer and the Immune System What is cancer? What is the immune response to cancer?

Ch. 21. Cancer and the Immune System What is cancer? What is the immune response to cancer? What are the prospects for immune therapies?. Cancer cells are out of control! Usually derived from a single cell, forming a neoplasm, or tumor Benign tumors are noninvasive;

671 views • 35 slides

Gamithromycin

Gamithromycin. A new azalide antibiotic for the treatment and control of Bovine Respiratory Disease. Andy Forbes, BVM&S PhD MRCVS Merial, Lyon, France. Outline. Product Profile Chemistry Pharmacokinetics Antibacterial activity Challenge studies European Field trials Registration

747 views • 32 slides

559 views • 27 slides

Overview of the Division of Viral Products

418 views • 27 slides

Immunization and immune testing Chapter 17

Immunization and immune testing Chapter 17. Immunizations. Two artificial methods to make an individual immune to a disease Active immunization -administration of a vaccine so that the patient actively mounts a protective immune response

596 views • 24 slides

Cancer and the immune system What is cancer? What is the immune response to cancer?

Cancer and the immune system What is cancer? What is the immune response to cancer? Prospects for immune therapies. Cancer cells are out of control! Usually derived from a single cell, forming a tumor Benign tumors are noninvasive; malignant tumors can invade and spread

386 views • 21 slides

Prevention and control of microbial infections

Prevention and control of microbial infections. Domitory 2222 Department of medicine From Shandong university. Prevention and Control of Microbial Infection . Interaction of microbes with host immune system determines - outcome of an infection and disease

389 views • 21 slides

Overview of the Division of Viral Products

Overview of the Division of Viral Products. February 28, 2014 VRBPAC Discussion of the August 28, 2013 Site Visit for the Laboratory of Respiratory Viral Diseases Jerry P. Weir, Ph.D., Director Division of Viral Products/OVRR/CBER/FDA.

395 views • 18 slides

Overview of the Division of Viral Products

Overview of the Division of Viral Products. Jerry P. Weir, Ph.D. Director Division of Viral Products/OVRR/CBER/FDA. Mission. Regulate viral vaccines and related biological products, ensuring their safety and efficacy for human use

363 views • 16 slides

Vaccines Against Viral Infection

Vaccines Against Viral Infection. Austin Follett Medicinal Chemistry. Anti-Viral Vaccines. History Vaccine types How they work Recommended Schedule Specific Vaccines Flu HIV/AIDS Human Papillomavirus (HPV) To stick or not to stick?. History of Vaccines.

351 views • 16 slides

LABORATORY OF RETROVIRUS RESEARCH: LAB STRUCTURE

LABORATORY OF RETROVIRUS RESEARCH: LAB STRUCTURE. SECTION OF RETROVIRAL PATHOGENESIS Hana Golding, Ph.D. (PI, Lab Chief) Keith Peden, Ph.D. (PI) Marina Zaitseva, Ph.D. (Senior Staff Fellow) SECTION OF RETROVIRAL IMMUNOLOGY Dennis Klinman, MD, Ph.D. (PI) SECTION OF MOLECULAR RETROVIROLOGY

357 views • 15 slides

Viruses

Viruses. 1897: a Dutch scientist suggested that something smaller than a bacteria could cause disease. 1935: Wendell Stanley isolated crystals of tobacco mosaic virus. Reasoned that living organisms do not crystallize, so he inferred that viruses were not truly alive. The Discovery of Viruses.

264 views • 12 slides

Overview of the Division of Viral Products

Overview of the Division of Viral Products. Site Visit for the Laboratory of Method Development July 26, 2011 Jerry P Weir, Ph.D. Director, DVP. Jerry P. Weir, Ph.D., Director Robin Levis, Ph.D.,Deputy. Laboratory of Retroviruses Hana Golding, Ph.D, Chief.

180 views • 7 slides

Opportunities in Viral Vaccines Industry in Healthcare

Recent research in vaccine technology with the help of application from genetic engineering is now providing opportunities to target new diseases and impact of this vaccination on the health of the world's people has been considerable.

146 views • 7 slides